Form 4: Champions Oncology Director Reports Stock Transaction
Insider Transaction (Form 4)
Joel Ackerman, a Director of Champions Oncology, Inc., reported multiple transactions in common stock on October 15, 2026.
Summary
- Option exercise/conversion: acquired 69,794 Common Stock at $1.60 ($111,670) on October 15, 2026; holds 1,126,333 after (Direct).
- Option exercise/conversion: disposed of 69,794 Option to purchase Common Stock at $1.60 ($111,670) on October 15, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Joel Ackerman — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-15 | Option exercise/conversion | Common Stock | 69,794 | $2 | $111.7K | 1,126,333 |
| 2026-10-15 | Option exercise/conversion | Option to purchase Common Stock | 69,794 | $2 | $111.7K | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-15 | Option exercise/conversion (69,794 shares) |
| 2026-10-15 | Option exercise/conversion (69,794 shares) |
Keywords
insider transaction, Form 4, CSBR, CHAMPIONS ONCOLOGY, INC., neutral, Joel Ackerman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.